Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Croda International has signed a 5-year contract to supply lipid-based excipients to Pfizer for production of the drugmaker’s messenger RNA–based COVID-19 vaccine candidate. The inactive ingredients will be made by Avanti Polar Lipids, a high-purity lipids firm that Croda acquired earlier this year. The up-to-$100 million contract specifies that Croda will provide four excipients for the first 3 years of the agreement. The drug services firms Lonza and CordenPharma earlier landed lipid supply deals with Moderna, another front-runner in COVID-19 vaccines.
This article has been sent to the following recipient: